Altimmune, Inc. Uncategorized Contracts & Agreements

47 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2025
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2024
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2023
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2022
Statement of Work SOW A-04 between Altimmune Inc. and Lonza Houston Inc. for Engineering and Qualification of Dedicated Manufacturing Suite
Services Agreements
Altimmune, Inc.
Biotechnology
2021
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2021
Description of Altimmune, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Altimmune, Inc.
Biotechnology
2020
Lock-Up Agreement between Altimmune, Inc. and Spitfire Pharma, Inc. Stockholders (July 2019)
Altimmune, Inc.
Biotechnology
2019
Altimmune, Inc. 2018 Inducement Grant Plan
Bonus & Incentive Agreements
Altimmune, Inc.
Biotechnology
DE
2018
Second Restated License Agreement between Crucell Holland B.V. and Vaxin Inc.
License Agreements
Altimmune, Inc.
Biotechnology
2017
Amendment No. 0001 to Contract HHSO100201600008C Between ASPR-BARDA and Altimmune, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2017
Research and Development Agreement for Ad5-Vectored Anthrax Vaccine Candidate Between Contractor and U.S. Government
Development Agreements
Altimmune, Inc.
Biotechnology
2017
Amendment No. 1 to Agreement and Plan of Merger among PharmAthene, Inc., Altimmune, Inc., and Others
Merger Agreements
Altimmune, Inc.
Biotechnology
DE
2017
Lock-Up Agreement between PharmAthene, Inc. and Altimmune, Inc. Stockholder
Altimmune, Inc.
Biotechnology
DE
2017
PharmAthene Lock-Up Agreement with Stockholder Regarding Merger with Altimmune, Inc.
Altimmune, Inc.
Biotechnology
DE
2017
Section 382 Rights Agreement between PharmAthene, Inc. and Continental Stock Transfer & Trust Company
Altimmune, Inc.
Biotechnology
DE
2015
Contract for Development of Vaccine Formulations Effective Against NIAID Priority Pathogens between PharmAthene, Inc. and NIH/NIAID
Services Agreements
Altimmune, Inc.
Biotechnology
2014
Post-Closing Lock-Up Agreement between PharmAthene, Inc. and Stockholder (Merger Consideration Shares)
Altimmune, Inc.
Biotechnology
2013
Board Composition Agreement among PharmAthene, Inc. and Certain Stockholders (2013)
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2013
Theraclone Voting and Lock-Up Agreement between PharmAthene, Inc. and Theraclone Stockholders
Voting Agreements
Altimmune, Inc.
Biotechnology
DE
2013
Employment Agreement between PharmAthene, Inc. and Eric Richman dated December 23, 2010
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
Early Conversion Agreement between Pharmathene, Inc. and Note Holders (October 2010)
Modification Agreements
Altimmune, Inc.
Biotechnology
DE
2010
Securities Purchase Agreement between PharmAthene, Inc. and Purchaser (July 20, 2010)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Placement Agent Agreement between PharmAthene, Inc. and Roth Capital Partners, LLC for Public Offering of Securities
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Exhibit 10.32 PharmAthene, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portionsdenoted by [***]
Altimmune, Inc.
Biotechnology
2010
Securities Purchase Agreement between PharmAthene, Inc. and Purchaser (April 7, 2010)
Purchase Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Placement Agent Agreement between PharmAthene, Inc. and Roth Capital Partners, LLC (April 7, 2010)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2010
Employment Agreement between PharmAthene, Inc. and Wayne Morges, Ph.D.
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
Employment Agreement between PharmAthene, Inc. and Eric Richman dated April 18, 2008
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2010
Variation and Settlement Agreement among PharmAthene, Inc., Avecia Entities, and Affiliates
Settlement Agreements
Altimmune, Inc.
Biotechnology
2009
Consent, Assumption, and Second Loan Modification Agreement among Silicon Valley Bank, Oxford Finance Corporation, and PharmAthene, Inc.
Modification Agreements
Altimmune, Inc.
Biotechnology
2009
Placement Agency Agreement between PharmAthene, Inc. and Rodman & Renshaw, LLC (March 23, 2009)
Underwriting Agreements
Altimmune, Inc.
Biotechnology
NY
2009
Indemnification Agreement between PharmAthene, Inc. and Indemnitee
Indemnification Agreements
Altimmune, Inc.
Biotechnology
DE
2009
Master Services Agreement between PharmAthene UK Limited and Avecia Biologics Limited (April 2, 2008)
Services Agreements
Altimmune, Inc.
Biotechnology
2008
Employment Agreement between PharmAthene, Inc. and Executive
Employment Agreements
Altimmune, Inc.
Biotechnology
MD
2008
Transitional Services Agreement between Avecia Biologics Limited and PharmAthene UK Limited (April 2, 2008)
Services Agreements
Altimmune, Inc.
Biotechnology
2008
Amendment Agreement to Sale and Purchase Agreement for Avecia Vaccines Business between Avecia Investments Limited, PharmAthene, Inc., and Others (April 2, 2008)
Modification Agreements
Altimmune, Inc.
Biotechnology
2008
Advisory Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (January 8, 2007)
Advisory Agreements
Altimmune, Inc.
Biotechnology
2007
Lock-Up Agreement Related to Healthcare Acquisition Corp./PharmAthene, Inc. Merger
Altimmune, Inc.
Biotechnology
2007
Insider Letter Agreement between Healthcare Acquisition Corp. and Maxim Group LLC (May 6, 2005)
Altimmune, Inc.
Biotechnology
2005